Solid Biosciences Inc.
SLDB
$6.57
$0.162.50%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.89% | 22.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.00% | 2.80% | |||
| Operating Income | -16.00% | -2.80% | |||
| Income Before Tax | -13.96% | -8.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.96% | -8.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.96% | -8.76% | |||
| EBIT | -16.00% | -2.80% | |||
| EBITDA | -16.30% | -2.63% | |||
| EPS Basic | 1.69% | -8.42% | |||
| Normalized Basic EPS | 1.70% | -8.42% | |||
| EPS Diluted | 1.69% | -8.42% | |||
| Normalized Diluted EPS | 1.70% | -8.42% | |||
| Average Basic Shares Outstanding | 15.92% | 0.33% | |||
| Average Diluted Shares Outstanding | 15.92% | 0.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||